Caco-2细胞模型及其对黄酮类成分作用机制研究进展

被引:24
作者
赵艳红
贾晓斌
陈彦
机构
[1] 江苏省中医药研究院江苏省现代中药制剂工程技术研究中心
关键词
Caco-2细胞模型; ADME/Tox; 黄酮类化合物; 吸收; 代谢;
D O I
暂无
中图分类号
R284 [中药化学];
学科分类号
100804 [中药化学];
摘要
Caco-2细胞模型作为ADME/Tox研究平台中肠吸收模型之一,已广泛用于药物动力学研究,可通过体外试验预测药物在体内的吸收和代谢,阐明药物在体内的吸收机制、毒性、药物吸收过程中的相互作用、药物的化学结构和体内转运关系以及药物代谢稳定性等。以黄酮类成分为代表,介绍Caco-2细胞模型在中药有效成分吸收代谢机制研究方面的应用进展。
引用
收藏
页码:938 / 941
页数:4
相关论文
共 8 条
[1]
Characterization of the absorption of theophylline from immediate- and controlled-release dosage forms with a numerical approach using the in vitro dissolution-permeation process using Caco-2 cells [J].
Noureddine, N ;
Zerrouk, N ;
Nicolis, I ;
Allain, P ;
Sfar, S ;
Chaumeil, JC .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2005, 31 (4-5) :397-404
[2]
Potential beneficial metabolic interactions between tamoxifen and Isoflavones via cytochrome P450-mediated pathways in female rat liver microsomes [J].
Chen, J ;
Halls, SC ;
Alfaro, JF ;
Zhou, ZH ;
Hu, M .
PHARMACEUTICAL RESEARCH, 2004, 21 (11) :2095-2104
[3]
Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model.[J].Jun Chen;Huimin Lin;Ming Hu.Cancer Chemotherapy and Pharmacology.2004, 2
[4]
Transcellular transport of genistein, a soybean-derived isoflavone, across human colon carcinoma cell line (Caco-2) [J].
Oitate, M ;
Nakaki, R ;
Koyabu, N ;
Takanaga, H ;
Matsuo, H ;
Ohtani, H ;
Sawada, Y .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2001, 22 (01) :23-29
[5]
Transport and Metabolism of the Tea Flavonoid (–)-Epicatechin by the Human Intestinal Cell Line Caco-2 [J].
Jaya Bharathi Vaidyanathan ;
Thomas Walle .
Pharmaceutical Research, 2001, 18 :1420-1425
[6]
Induction of UDP-Glucuronosyltransferase UGT1A1 by the Flavonoid Chrysin in Caco-2 Cells—Potential Role in Carcinogen Bioinactivation [J].
Alema Galijatovic ;
Yoko Otake ;
U. Kristina Walle ;
Thomas Walle .
Pharmaceutical Research, 2001, 18 :374-379
[7]
Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells [J].
Walgren, RA ;
Walle, UK ;
Walle, T .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (10) :1721-1727
[8]
THE CACO-2 CELL MONOLAYERS AS AN INTESTINAL METABOLISM MODEL - METABOLISM OF DIPEPTIDE PHE-PRO [J].
HU, M ;
CHEN, J ;
TRAN, D ;
ZHU, Y ;
LEONARDO, G .
JOURNAL OF DRUG TARGETING, 1994, 2 (01) :79-89